PAA
MDT icon

Peregrine Asset Advisers’s Medtronic MDT Stock Holding History

Peregrine Asset Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Buy
+6,322
New +$510K 0.11% 138

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Peregrine Asset Advisers's MDT Position: Q2 2026 in Review

Peregrine Asset Advisers opened a new position in Medtronic (MDT) in Q2 2026: 6,322 shares worth $495K. The stake represents 0.11% of the portfolio and ranks #138 among its holdings.

2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Peregrine Asset Advisers held 6,322 shares of Medtronic worth $495K as of Q2 2026.
  • Medtronic was a new Peregrine Asset Advisers position in Q2 2026.
  • Medtronic made up 0.11% of Peregrine Asset Advisers's portfolio in Q2 2026, its #138 holding.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.